10.23.14
Expanding Orthopedics Inc., a privately held medical device company focused on expandable devices for spine surgery, has been granted its 13th U.S. patent, adding to its intellectual property portfolio for expandable bone devices.
Mark Levy, M.D., an orthopedic surgeon and founder of Israel-based Expanding Orthopedics, said: “My vision, since I founded the company, was to develop a unique family of expandable devices covering spine and trauma applications, creating a new standard of care. This 13th granted U.S. patent covers innovative technologies in the area of expandable interbody cages and VCF (vertebral compression fracture) solutions. This confirms our ability to develop together, with our advising surgeons, state-of-the-art devices which, ultimately, provide patients with improved clinical outcome.”
"This new patent demonstrates our continuous commitment to innovation and reinforces our position as a leading innovator in the area of expandable devices,” said Ofer Bokobza, the company’s CEO. "While our sales and marketing team is currently focused on bringing the FDA (U.S. Food and Drug Administration)-cleared FLXfit 3-D expandable cage to the U.S. market, our engineering team continues to work on the next generation of expandable devices to meet surgeons' evolving needs. We are dedicated to a continuous pursuit of raising the bar in providing a new standard of care in spine surgery.”
The FDA cleared the FLXfit in July.
Mark Levy, M.D., an orthopedic surgeon and founder of Israel-based Expanding Orthopedics, said: “My vision, since I founded the company, was to develop a unique family of expandable devices covering spine and trauma applications, creating a new standard of care. This 13th granted U.S. patent covers innovative technologies in the area of expandable interbody cages and VCF (vertebral compression fracture) solutions. This confirms our ability to develop together, with our advising surgeons, state-of-the-art devices which, ultimately, provide patients with improved clinical outcome.”
"This new patent demonstrates our continuous commitment to innovation and reinforces our position as a leading innovator in the area of expandable devices,” said Ofer Bokobza, the company’s CEO. "While our sales and marketing team is currently focused on bringing the FDA (U.S. Food and Drug Administration)-cleared FLXfit 3-D expandable cage to the U.S. market, our engineering team continues to work on the next generation of expandable devices to meet surgeons' evolving needs. We are dedicated to a continuous pursuit of raising the bar in providing a new standard of care in spine surgery.”
The FDA cleared the FLXfit in July.